Participant flow20

How many started, completed or left each group, period by period.

1 to 20 of 20

Period	Milestone	Group	Participants
Overall Study	STARTED	RC: Erlotinib	623
Overall Study	STARTED	RC: Placebo	350
Overall Study	STARTED	BPC-NOLC: Erlotinib/Placebo	134
Overall Study	STARTED	BPC-NOLC: Placebo Only	11
Overall Study	STARTED	BPC-OLC: Erlotinib	132
Overall Study	Received Treatment	RC: Erlotinib	612
Overall Study	Received Treatment	RC: Placebo	342
Overall Study	Received Treatment	BPC-NOLC: Erlotinib/Placebo	134
Overall Study	Received Treatment	BPC-NOLC: Placebo Only	7
Overall Study	Received Treatment	BPC-OLC: Erlotinib	132
Overall Study	COMPLETED	RC: Erlotinib	253
Overall Study	COMPLETED	RC: Placebo	197
Overall Study	COMPLETED	BPC-NOLC: Erlotinib/Placebo	0
Overall Study	COMPLETED	BPC-NOLC: Placebo Only	0
Overall Study	COMPLETED	BPC-OLC: Erlotinib	60
Overall Study	NOT COMPLETED	RC: Erlotinib	370
Overall Study	NOT COMPLETED	RC: Placebo	153
Overall Study	NOT COMPLETED	BPC-NOLC: Erlotinib/Placebo	134
Overall Study	NOT COMPLETED	BPC-NOLC: Placebo Only	11
Overall Study	NOT COMPLETED	BPC-OLC: Erlotinib	72

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00373425/flow